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Abstract
The  miniaturization  of  reactions  by  designing  nanoliter-scale  PCR  platforms,  as
Taqman® OpenArray®, Dynamic Array™, or SmartChip, has been a big step forward
in real-time PCR. Each platform has some particular characteristics that differentiate
them. These nanoliter-scale PCR platforms enable substantial savings in the amount
of  reagents  and  sample  because  the  reaction  volumes  are  at  nanoliter  levels.  In
addition, it is possible to perform thousands of reactions in a few hours. Therefore,
high-throughput real-time PCR platforms result in promising systems that are capable
of processing a large number of samples simultaneously and also to perform a large
number of assays per sample. All of this can be translated in the amazing applicability
of this technology in all kinds of analytical fields, such as medical research, animal
science, and food safety, among others.
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1. Introduction
In the decade of the nineties, real-time PCR became popular and meant an important step in
molecular biology because of the great advantages over conventional PCR biology and its
quantitative abilities. This revolution in PCR methods was achieved, thanks to the use of
intercalating fluorophores, specific labeling probes with fluorescence emission, as well as
equipment with the ability to detect this fluorescence during the reaction [1]. In this way,
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measurement  of  gene  expression,  absolute  quantification  of  pathogens,  and  genotyping
analysis became routine analysis in life science research.
Until now, the limiting factor for real-time PCR compared to other molecular techniques was
the number of tests that could be performed simultaneously. For example, hybridization
techniques using microarrays, as those designed by Illumina® and Affimetrix®, allow the
analysis of thousands of genetic markers in one single array [2, 3]. The realization of this type
of screening by real-time PCR in standard formats (384 and 96 microwell plate) is infeasible
due to both operational and economic reasons. In this context, in the few last years, some
companies started to develop real-time PCR methods using a smaller reaction volume. As a
beginning, some options for sample miniaturization such as the TaqMan® array microfluidic
cards designed by Applied Biosystems® or the arrays designed by Qiagen® became available
in the market. These formats use small volume that minimizes sample and reagent consump-
tion. Their use is nowadays very popular in the field of gene expression, where it is possible
to find predesigned array cards for certain diseases and metabolic pathways [4, 5]. They have
also applications in other fields as microRNA screening or detection of foodborne pathogens
[6, 7]. However, this improvement in the number of assays and samples that can be analyzed
at the same time is still far away from the capabilities of microarray techniques.
The development of real-time high-throughput platforms was a breakthrough that changed
the perception about real-time PCR and their possibilities. From the very beginning, the use
of nanoliter reaction volumes and the possibility of custom designs converted this technology
into an attractive tool for research purposes. Thus, this nanoliter-scale PCR became very
common in fields such as medicine and pharmacogenomics research, allowing the inclusion
of large number of assays and samples in one run. All the previous features have positioned
real-time PCR in direct competition with microarrays and next-generation sequencing, also
because it is a more sensitive and specific technique.
2. Principles and available high-throughput real-time PCR platforms
Currently, there are three commercially available high-throughput real-time PCR platforms:
Dynamic Array™ chip (Fluidigm®, South San Francisco, CA, USA) TaqMan® OpenArray®
(Applied Biosystems®, Carlsbad, CA, USA), and SmartChip (Wafergen Bio-systems Inc.,
Fremont, CA, USA). The operating principle of the three high-throughput platforms is the use
of a nano-scale approach with thousands of reactions in a single run, reducing the sample and
reagents consumption to the minimum. However, there are very important differences
depending on the platform used.
2.1. Dynamic array
Microfluidic Dynamic Array™ with the integrated fluidic circuit (IFC) along with Biomark™
System from Fluidigm was the first real-time high-throughput platform available in the
market [8]. The design of Dynamic Array™ is based on an integrated network of channels,
chambers and valves that automatically combine the reactions. Thus, the dynamic plate is
Polymerase Chain Reaction for Biomedical Applications16
formed mainly by three components. On the one side, there are separate sample inlets, one for
each sample. On the other side, there are separate primer-probe inlets, one for each probe. The
IFC is placed in the middle, and it is here where the reaction chambers are located. This
mechanism uses manual pipetting to load samples and primers-probes, and avoids the use of
robotic liquid-handling to set up microwell plates. However, this kind of plates needs another
instrument (IFC controller) controlled by a software to pressure load the assay components in
the wells of the IFC in a process of 55 min. These wells, called reaction chambers, are formed
by two containment valves and one interface valve. Thus, pressure is applied to the fluids
contained in sample and detector inlets simultaneously. In this way, the fluids are transported
into reaction chamber and fluid lines, respectively. The interface valve prevents sample and
detector fluids from mixing. Then, the two containment valves are closed and interface valve
is opened, pushing the detector fluid into the reaction chamber for mixing with the sample.
Once the components are properly mixed, the interface valve is closed again and the chip is
ready for cycling [9]. The real-time PCR cycling is performed in the BiomarkTM System. At the
end of each cycle, the chip is imaged and at the end of the whole process, the software generates
PCR curves and a heat map, where each square represents a reaction chamber and the color
indicates the CT value.
IFC 48.48 Dynamic
Array IFC
96.96 Dynamic
Array IFC
192.24 Dynamic
Array IFC
FLEXsix IFC
Application Genotyping/gene
expression
Genotyping/gene
expression
Genotyping/gene
expression
Genotyping/gene
expression
Pipetting steps 96 192 216 Variable
Assay inlets 48 96 24 6×12
Sample inlets 48 96 192 6×12
Reactions chambers 2304 9616 4608 864
Reaction volume (nl) 9 7 8 9
Table 1. Dynamic array chips commercially available and their principal characteristics.
The company has a web tool [10] to customize assays for genotyping and gene expression with
the specific conditions in which works, Dynamic Array™. There are different designs of
Dynamic Array™ chips (Table 1) with reaction volumes ranging from 7 to 9 nl, depending on
the array [11]. Of all the available nanoliter-scale platforms, Dynamic Array™ uses the smallest
reaction volumes, while the other platforms use volumes of 33 and 100 nl. FLEXsix IFC is the
model with the least number of reaction chambers (864). However, it can be considered as a
model to select targets and to optimize assay. It has 6 partitions that allow 12 performing
samples and 12 assays per sample in independent runs. The next designs in terms of number
of chambers are 48.48 Dynamic Array™ and 96.96 Dynamic Array™ that analyze 48 and 96
samples and assays per sample, respectively. These three models can be used both for geno-
typing and gene expression assays. The last model was called 192.24 Dynamic Array™ and it
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allows performing 24 assays per sample and 192 samples. As an example of their great
processing capability and taking into account the whole workflow, the 96.96 Dynamic Array™
enables 9216 reactions in less than 4 h and it is capable to generate 36,000 data points per person
and day. Despite the clear potential of these four designs available to the customer, Dynamic
Array™ systems lack intermediate formats or even bigger dynamic chips that would allow the
realization of a greater number of assays per sample.
One of the main advantages of Dynamic Array™ platforms compared to their direct competi-
tors is the flexibility derived from the inexistence of preprinted assays. Dynamic Array™ has
the possibility to choose the analyses that are going to be performed in each run. Although this
flexibility is a clear advantage, the platform has problems of compatibility with TaqMan® as-
says. While in OpenArray® platform the same company designs and preprints the assays, in
Dynamic Array™ another company provides the primers and probes, resulting in the subse-
quent problems of compatibility. These problems have been observed already in some inter-
comparative studies. For instance, Fedick et al. [12] used Dynamic Array™ and OpenArray®
platforms for genotyping members of the Ashkenazi Jewish community. They observed prob-
lems of compatibility with the design of TaqMan® probes for genotypic analysis with Dynamic
Array™. This incompatibility reduced the sensibility and the specificity of the assay in com-
parison with OpenArray®. Also, Farr et al. [13] detected problems of compatibility between RT
primers and TaqMan® assays when Dynamic Array™ was employed for microRNA screen-
ing. These problems of compatibility could be solved simply by implementing a meticulous
design of custom primers, which are adapted to Dynamic Array™ conditions.
2.2. TaqMan® OpenArray®
TaqMan® OpenArray® (Applied Biosystems) was the second high-throughput platforms
released in the market. In the year 2006, Morrison et al. [14] published the Biotrove Inc (MA,
USA) design of a through-hole array. It was composed of 3072 holes of 33 nl reaction volume
in 48 groups of 64 holes each one. These plates have a hydrophobic exterior surface and
hydrophilic interior (the inside surface of the 33 nl holes). This intelligent design allows fluid
deposited on the hydrophobic surface to move into the hydrophobic holes. These arrays
require the use of the OpenArray® NT autoloader for loading plates and the OpenArray® NT
cycler for running the array [15]. In 2009, this technology was acquired by Applied Biosys-
tems®, which now is a part of Thermo Fisher Scientific (MA, USA). For this reason, presently
the OpenArray® technology works with OpenArray® AccuFill™ System for loading samples
and the QuantStudioTM 12K Flex real-time PCR system that allows running four OpenArray®
plates at the same time. The main applications described for this instrument up to now are
gene expression, genotyping, microRNA screening, or drug metabolism analysis.
The first difference with the Dynamic Array™ is that in the OpenArray® design, the primers
and probes are preloaded in the holes by the company. As a result, the user only needs to load
the samples and the PCR mix onto the plate. However, the primers and probes cannot be
changed while with Dynamic Array™ it is possible to choose which primers are used in the
reaction if we have a library of them. On the other hand, the number of plate designs available
for the customer with OpenArray® technology is higher.
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The first step in an experiment with OpenArray® is to decide the right plate design that is
convenient for the number of samples and assays per sample we want to perform. The division
of the plate in 48 subarrays of 64 holes each allows variable designs, which are different for
gene expression and genotyping assays (Table 2). The customers place the order for the desired
design through an application on the web page of Thermo Fisher Scientific. It is possible to
find millions of predesign TaqMan® assays in the database of the company, all of them
successfully tested by the manufacturer. In addition to them, the costumer can order his custom
assays by loading the target sequence in the web page and the company would design then
the primers and the probes according to the real‐time PCR conditions in which OpenArray®
technology works. It is also possible to obtain some predesigned OpenArray® plates com‐
mercially available for specific genotyping and gene expression purposes. For example, there
are OpenArray® plates for human identification and for expression of inflammation, cell‐stem,
or cancer‐related genes [16]. Also, there is an OpenArray® plate for screening of microRNA
in human samples [17].
Format Gene expression Genotyping
Number of assays Number of samples Format Number of assays Number of samples
18 18 × 3* 48 16 16 144
56 56 48 32 32 96
112 112 24 64 64 48
168 168 16 128 128 24
224 224 12 192 192 16
256 256 12
* In format 18×3 the assays are performed in triplicate.
Table 2. OpenArray® formats for genotyping and gene expression available for the costumers.
The two most widely used approaches to generate fluorescence in real‐time PCRs are SYBR®
Green and labeled probes. SYBR® Green is a chemical reagent that is introduced into the
secondary structure of the DNA double helix. Consequently, the more the PCR products
formed the more the fluorescence emitted. This molecule is commonly used in gene expression,
mainly due to their affordable price. SYBR® Green allows the obtainment of a larger number
of tests at a relatively low price. With regard to labeled probes, these nucleotide sequences
were designed with the purpose of increasing the specificity of quantitative PCR. These probes
bind to the middle of the target sequence, which is going to be amplified. They are labeled in
the 5′ end of their structure with a fluorophore that will be released when the target section is
amplified, resulting in fluorescence emission during amplification. Labeled probes are usually
preferred in genotyping assays because using two labeled probes with two different fluoro‐
phores in the same reaction is possible to differentiate the two alleles. In the early development
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of OpenArray®, most of the experiments were performed using SYBR® Green [14, 15, 18]
instead of TaqMan® Probes. However, nowadays this technology works mostly with TaqMan®
probes both for genotyping and gene expression, because they increase the specificity of the
assays and data processing is easier.
A characteristic trait of OpenArray® plates is that they need to be loaded with the help of
OpenArray® AccuFill™ System, while Dynamic ArraysTM are loaded manually. This does not
mean a saving in equipment, because Dynamic ArraysTM needs another apparatus to transfer
the samples and the primers to the reaction chambers. Moreover, this transfer process takes 55
min, while loading plates with OpenArray® AccuFill™ System only takes a few minutes. With
OpenArray® AccuFill™ the process is very simple. First, the samples are mixed with the
Master Mix in a 384-well plate. The order of the samples on this plate depends of the Open-
Array® format that is going to be used. Afterward, the tip system of the OpenArray® Accu-
Fill™ equipment transfers each sample to the corresponding subarray, showing a specific
movement according the chosen array format. The sample is deposited in the hydrophobic
surfaces of the array and the liquid is naturally transferred to the hydrophilic 33 nl holes. Once
the array is filled, it has to be properly sealed and it is ready for the real-time PCR analysis.
One of the great advantages of the OpenArray® system is that is possible to run four plates at
the same time. Since the whole real-time PCR process takes about 4 h, in just one run 12,288
data points can be obtained.
The huge amount of data originated during an OpenArray® experiment resulted in the need
for specific software that would enable to handle the results. For this, there are two options to
process OpenArray® data. One is the software that controls the equipment and the other
option is using the analytical platform available on the net. Thermo Fisher Scientific has created
a Cloud where the user can upload the experiment files and analyze them with no need of
installing anything on the computer. The Cloud also offers the possibility of sharing the files
with another person, so that several people from different sites can work on the same files.
TaqMan® OpenArray® plates have a characteristic that may be considered as an advantage
and a disadvantage at the same time, the preprinted primers. When custom plates are ordered,
the company designs the primers and probes for the target sequence according the OpenAr-
ray® working conditions, and preprints them in each hole of the plate. The advantage is that
the company performs quality control assays, but the problem is that the minimum order in
the custom mode is 10 plates per order. Thus, if the researchers are not satisfied with the results
obtained for some assays or even if they want to change the design, they have to order another
10 plates, with the subsequent economic costs.
2.3. SmartChip
In 2010, the last high-throughput platform was released to the market under the commercial
name of SmartChip real-time PCR system (WaferGen Biosystems, CA, USA). This technology
is based on a chip of 5184 individual wells. Within the three available technologies described
until now, this is the one that uses the largest volume of reaction: 100 nl per reaction [95].
SmartChip has some characteristics that make it stand out from Dynamic Array™ and
OpenArray®. A clear advantage of SmartChip systems is that they allow profiling of more
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than 1000 genes in a single run and in quadruplicate. These platforms would therefore enable
the user to perform a screening of genes closer to the amplitude of microarrays technologies
than those obtained with the other two systems. However, the number of samples that can be
analyzed in this case is only one per run. In fact, the company describes the SmartChip
technology in three basic steps: (1) discovery: analyzing hundreds to thousands of genes, (2)
validation: analyzing tens to hundreds of genes and (3) screening: analyzing tens of genes as
informative genes of a disease signature. In addition to the top model >1000 genes format of
SmartChip, the company offers also customized formats for specific hypothesis-based
purposes. These formats permit the inclusion of 384 to 12 samples in a single chip (Table 3).
Assay configuration  Samples analyzed at the same time 
1243  1 (in quadruplicate) 
12  384 
24  216 
36  144 
48  108 
54  96 
72  72 
80  64 
96  54 
120  42 
144  36 
216  24 
248  20 
296  16 
384  12 
Table 3. Possible configuration of SmartChip panel for custom analysis.
The company offers three ready-to-use predesigned panels: the SmartChip Human Oncology
Panel with 968 gene-specific assays in quadruplicate, the SmartChip Human microRNA Panel
with 778 microRNA-specific assays in quadruplicate, and a SmartChip Bacterial Vaginosis
Panel that includes 19 pathogens common in woman vaginosis. For custom assays, it is
necessary to send the sequences to the company service. With this information, they design
the primers according to the specific conditions of the SmartChip real-time PCR and preload
them into the chip. Until now, this technology has been applied mainly in gene expression
studies, working only with SYBR® Green chemistry.
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The SmartChip complete system is composed of a cycler and a dispenser, with the corre-
sponding required software. For loading or dispensing the samples on the chip, the user has
two options. The SmartChip nanodispenser, to dispense only one sample in the entire chip,
and designed specifically for the >1000 panels, and the SmartChip multisample nanodispenser,
created for loading up to 384 samples on a single chip. In both options, the loading time is less
than 10 min. Afterward, the chips are run in a SmartChip cycler, in a process that lasts 2 h. The
obtained data would be analyzed with the SmartChip qPCR software.
3. Application fields of high-throughput real-time PCR platforms
3.1. Genotyping
3.1.1. Basic concepts of genotyping
One of the most promising applications of high-throughput real-time PCR in science is
genotyping. This technique is based on the analysis of single nucleotide polymorphisms
(SNPs) of the DNA. SNPs are single base pairs in a specific position of genomic DNA where
different sequence alternatives, the alleles, exist in normal individuals in the population and
the minor allele has an abundance of 1% at least [19]. The DNA is composed of four different
nucleotides: adenine, guanine, thymine, and cytosine. Thus, in theory the SNPs could be tetra-
allelic but in practice, this is a rare situation and normally SNPs are bi-allelic. As such, this type
of genetic polymorphism is very common in genomic DNA of mammals. For example, around
1.4 million of single-nucleotide polymorphisms have been identified in the initial sequencing
of the human genome, of which 60,000 are located in the coding region of genes [20]. The
importance of SNPs is huge because these nucleotide modifications can be silent but they can
also be responsible for the predisposition to certain diseases or be the direct cause of them. For
instance, there are some studies that have related the presence of certain SNPs in individuals
with diabetes, obesity, hypertension, or even cancer [21–24].
The development of next-generation sequencing (NGS) and microarrays have allowed the
discovery and analysis of hundreds of thousands of SNPs [25]. However, broad screening
approach has also a few drawbacks. For example, to study the presence of certain SNPs
associated with a disease in a population the number of SNPs that are going to be analyzed is
as important as the number of samples that can be processed simultaneously. This is exactly
where real-time PCR gains importance over other technologies. In this context, there are two
common techniques to detect single nucleotide polymorphisms with real-time PCR. The first
option is using SYBR® Green and melting curve analysis. This method is based on detecting
small differences in PCR melting (dissociation) curves after real-time PCR cycles. These
differences in the dissociation curve allow to detect the differences in a single nucleotide [26].
The other option is based on the use of probes, applying two probes with different 5′-end
labeling in the same reaction. Thereby, if both the fluorophores are detected it means that the
sample is a heterozygote for the target DNA region. On the contrary, if the equipment only
detects one of the fluorophores the sample is a homozygote. The major problem of selecting
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real-time PCR for genotyping analysis is the high costs involved in analyzing a wide range of
samples and SNPs, mainly due to prices of probes and master mix. High-throughput real-time
PCR platforms made PCR an ideal tool to analyze SNPs, thanks to their nanoscale working
capacity and the consequent saving of reagents and samples. One of the research areas that
have more directly benefited from this technology is human medicine. The previous fact is
based on the possibility of including a large number of samples and assays in one day of work.
This can be translated into the tracking of a large number of SNPs per sample, in order to assess
their influence on the development of certain diseases.
3.1.2. High-throughput real-time PCR in genotyping
In 2011, Chan et al. [27] evaluated the use of the Fluidigm 48.48 Dynamic Array biochip for
genotyping purposes in clinical setting, using peripheral blood and buccal wash samples,
obtaining promising results. PCR has found its place also in cancer research and it has been
widely used already. In a recent study, Henríquez-Hernández et al. [28] compared the classical
method of PCR restriction fragment length polymorphism (RFLP) and the high-throughput
automated assay Biotrove OpenArray(®) NT cycler, using them for genotyping 118 patients
with cancer. Their results suggest that the modern PCR technology is more viable and
reproducible than the traditional RFLP method. They concluded that OpenArray® technology
can be considered as a robust, simple handling, and user-friendly tool for genotyping purposes
in the field of oncology. Henríquez-Hernández et al. [29] also used the potential of this tool to
evaluate the influence of the SNPs present in a population with prostate cancer in radiation-
induction toxicity. In a different study, Henríquez-Hernández [30] evaluated the influence in
prostate cancer of genetic variations in genes involved in testosterone metabolism and found
one polymorphism characteristic of Spanish patients. Another example is the research
performed by Julin et al. [31] using TaqMan® OpenArray® genotyping assay to correlate the
leukocyte telomere length and the overall risk of aggressive prostate cancer. In a similar
approach, Zhao et al. [32] used genotyping assay with OpenArray® technology to evaluate
the influence of SNPs of 16 antioxidant genes in the increased risk of glioma.
Apart from oncology, this technology has demonstrated its applicability in other fields of
medicine. For instance, some authors have reported the influence of SNPs in the risk of
developing Type 2 diabetes [33], their relationship with male fertility, or even the existence of
a link between polymorphisms and smoking in male fertility [34, 35]. In a very recent work of
Araujo and coworkers [36], the association of 39 genes and the etiology of nonsyndromic cleft
lip and palate in Brazilian population was evaluated. In the field of dermatology, Villarreal
Martínez et al. [37] found an association between six SNPs and the risk of developing psoriasis.
Apart from the clear role of high-throughput real-time PCR in experimental science, another
possibility of this technique in human medicine is its application in molecular diagnostic
testing in a hypothesis-based manner. For instance, Arrojo Martins et al. [38] used OpenArray®
plates for screening mutations involved in nonsyndromic deafness. Dionisio Tavares Niewia-
donski et al. [39] applied the same approach for genetic testing of blood donors to assess the
genotype frequencies of nucleotide-polymorphisms (SNPs) associated with venous thrombo-
sis, hyperhomocysteinemia and hereditary hemochromatosis. High-throughput platforms
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have also managed to find their way in pharmacogenomics research. They are very useful in
this kind of studies because of the possibility of testing a wide range of SNPs with implications
in drug metabolism in a fast and cheap way. In this sense, Iskakova et al. [40] studied SNPs
involved in the absorption, distribution, metabolism, and excretion of multiple drugs in
Kazakhs. Also, it makes possible the development of personalized treatments according to
individual genetic characteristics.
Another promising application of this nanoliter-scale PCR in combination with SNPs is
individual identification and paternity test. Until a few years ago, short tandem repeats (STRs)
were the most common genetic markers used for individual identification, paternity, and
kinship testing [41]. STR consists of a unit of 2–13 nucleotides repeated hundreds of times in
a row on the DNA strand. STR analysis measures the exact number of repeating units. This
fact makes STRs more informative than SNPs in genetic analysis because SNPs remain only in
a nucleotide variation [42]. However, this lack of information can be solved by simply including
more SNPs in the assay. As an indicative example, a number of 2–2.25 SNPs give the same
information than 1 STRs [43]. In comparison to STR assays, high-throughput real-time
platforms make feasible the use of SNPs for individual and paternity analysis, both for humans
and animals, because of its relatively affordable price, the number of samples that can be
analyzed in a run and the easier analysis of the obtained results. In a similar context, Pomeroy
et al. [44] developed an OpenArray® to be used for forensic human DNA applications, with
only seven SNPs for individual identification. In the same year, Wang et al. [45] showed the
possibilities of other nanoliter-scale platform, the Fluidigm 48.48 Dynamic array, for genotyp-
ing purposes in human. In an interesting work by Kerr et al. [46], OpenArray® panel with 32
SNPs was used to create a pedigree of the Scottish by the analysis of 10,000 blood samples. It
is also possible to find commercial arrays for human identification. In this sense, Thermo Fisher
Scientific has predesigned OpenArray® for human individual identification with 32 and 64
SNPs.
Individual identification is also important in food safety to ensure traceability according to
Commission Regulation (EC) 178/2002 [47]. Molecular genetic analysis and more precisely
SNPs are a useful tool for this purpose. Capoferri et al. [48] used 16 SNPs to verify traceability
of the meat production chain with successful results. However, this study used a 96-well plate
real-time PCR assay with the consequent high consumption of reagents and had the limitation
of not being capable of analyzing a large number of samples at the same time. High-throughput
real-time PCR platforms solved these problems, as demonstrated by Fernández et al. [49] and
Pozzi et al. [50] who developed a OpenArray® panel with 32 SNPs that allow individual and
cattle rustling identification. For an analytical target of 32 SNPs, this nanoscale technology
permits to analyze 96 samples per array. Besides, QuantStudio™ 12 K flex is capable of running
four OpenArray® plates at the same time, in a process of only 4 h. Thus, in a working day of
8 h, 768 samples can be analyzed. This number reflects the enormous possibilities of high-
through real-time PCR.
Many other areas of life science research, such as animal and plant sciences, can benefit as well
from the diverse advantages of nanoliter-scale platforms. Recently, Catanese et al. [51]
developed a panel of 96 SNPs with the aim of genotyping anchovy populations. It is notewor-
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thy that they selected these best 96 markers from a panel of 424 SNPs using an OpenArray®
platform, and then they selected Fluidigm 96.96 Dynamic Array™ for routine analysis due to
economic reasons. One of the important points in agriculture is the breeding of crops with
certain characteristics of productive interest. In different studies, a panel of 192 SNPs was used
for the study of genetic diversity in sugar beet, to study the vigor of the genotypes, and to
assess the resistance of these plants to pathogens [52–55].
To sum up, the existing literature clearly indicates the great potential of high-throughput real-
time platforms for genotyping. In the future, it could become routine technique, for example,
in assessing individual patients in order to test their predisposition to certain diseases through
the use of predetermined SNP panels. These panels would allow an early change of habits,
reducing the possibility of suffering from certain diseases such as Type 2 diabetes or obesity.
In this way, nutrigenetics has become an important research field, studying how the different
genetic variants of people influence their metabolism of nutrients, diet, and the diseases
associated therewith [96]. The development and commercialization of SNP panels for which
their influence in nutrition-related diseases has been demonstrated would be a big step forward
in personalized nutrition.
3.2. Transcriptomics
3.2.1. Basic concepts in transcriptomics
Transcriptomics, in its many forms, refers to the study of the expression profiles of genes
through the complete set of RNA transcripts (transcriptome). This revolutionary ``omic´´
technology comprises different techniques as microarrays, RNA sequencing, and real-time
PCR. Until now, only microarrays and RNA-NGS allowed genome-wide surveys. However,
these two methods have some drawbacks. Microarrays can only detect sequences homologous
to the one that is on the array, and RNA-NGS is costly and the analysis of results required
highly specialized technicians. Also, RNA-NGS is perfect for blind studies but not sufficiently
adequate for targeted analysis. Real-time PCR is a highly quantitative and sensitive technique
suitable for different transcriptomics aims. However, 384- and 96-well plates only allow the
analysis of a small number of transcripts and samples at the same time. In this context, high-
throughput real-time PCR platforms represented a step forward and placed real-time PCR
closer to microarrays and RNA-NGS.
3.2.2. High-throughput real-time PCR in mRNA-based transcriptomics
The most classic part of transcriptomics is the study of messenger RNA (mRNA). It has great
interest in life sciences because mRNA is the intermediate step between the genes and the
proteins. In this sense, the analysis of the modifications in gene expression levels through
mRNA is an important tool which gives us an idea of the influence of internal and external
factors in gene expression. For the quantification of mRNA levels by real-time PCR, a previous
conversion of mRNA to cDNA, the template of PCR, is needed. This quantification could
absolute or relative to a control gene. Although probes are more specific than SYBR® Green,
this last chemistry is normally the option chosen for gene expression, mainly due to economic
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reasons. The first studies evaluating the possibilities of high-throughput real time PCR
platforms were performed for gene expression assays by Morrison et al. [14], who evaluated
the possibilities of OpenArray® technology. Although nowadays OpenArray® technology
works with TaqMan® probes, the first study used SYBR® Green chemistry. These researchers
reported already the need of increasing sample concentration through volume miniaturization,
in order to maintain a constant number of target molecules in the reaction. In 2008, Spurgeon
et al. [9] evaluated the 48.48 Dynamic Array™ chip for gene expression purposes. Thanks to
their studies, a preamplification step of cDNA samples was added for these dynamic platforms
before real-time PCR analysis, with the aim of maintaining a high level of target molecules in
the reaction. However, this preamplification reaction means that a new step needs to be
included in the experimental high-throughput workflow, increasing the total processing time
and costs.
As in the case of genotyping applications, in transcriptomics human medicine was the first
field benefited with the development of nanoliter-scale real-time PCR. In 2012, Chen et al. [56]
used a SmartChip real-time PCR platform to evaluate gene expression in colon cancer, while
Javelaud et al. [57] used OpenArray® technology to evaluate the expression of hundreds of
genes in melanoma cell-lines. An interesting application was carried out by Li et al. [58] using
OpenArray® to quantify gene expression from degraded RNA of formalin-fixed paraffin-
embedded tumors. They concluded that this platform could be optimized for gene expression
in this kind of preserved samples, opening an interesting avenue of research in cancer. In breast
cancer, Song et al. [59] evaluated the expression of 1243 mRNA in breast tissue using SmartCh-
ip, showing the potential of this technology to analyze the transcriptome in a similar level of
microarrays. However, the SmartChip of 1243 only allows the analysis of one sample in
quadruplicate (Table 3). The results obtained with OpenArray® plates led the team of Ciarloni
et al. [60] to validate a panel of 29 genes with interest in colorectal cancer, starting with an
initial panel of 667 candidate genes. In a similar way, Kim et al. [61] validated a panel of eight
promising genes in patients with metastatic renal cell carcinoma from an initial panel of 424
genes. Other examples of the application of high-throughput platforms in medicine studies
include the work from Patel et al. [62], who employed an OpenArray® panel of 631 genes to
evaluate gene expression in human embryonic and induced pluripotent stem cells. Koh et al.
[63] employed Fluidigm 48.48 Dynamic Array™ for monitoring the tissue-specific global gene
expression in humans thought circulating cell-free RNA in the blood. Thus, this real-time
method could be employed for transcriptome analysis of humans and evaluate their global
health without the need for invasive tissue sampling.
The work carried out by Forreryd et al. in 2014 [64] deserves special mention. They assessed
different high-throughput gene expression platforms to predict skin sensitization without the
use of animals. The study used Fluidigm® 96.96 Dynamic Array™ and OpenArray® with
nCounter®. The OpenArray® system demonstrated the easier protocol and the less time
required for analysis, obtaining the results in 3 h, in contrast to the 7 h of Fluidigm® 96.96
Dynamic Array™ and the 22 h of nCounter®. However, Fluidigm® 96.96 Dynamic Array™
had a superior sensitivity due to the additional cDNA preamplification step implemented prior
to PCR and it was also the cheapest option. Likewise, the authors suggested the importance
Polymerase Chain Reaction for Biomedical Applications26
of selecting appropriate reference genes because one of the two reference genes employed in
the study did not amplified well. The final authors’ conclusions reflected the great potential
of nonarray-based platforms for reducing assay costs and increasing sample throughput.
Finally, the results of this comparative study highlight the importance of establishing clear
priorities in terms of sensibility, analytical time, and costs when acquiring a high-throughput
platform.
Besides medicine, other research fields have also benefited from the capacities of high-
throughput real-time PCR. For instance, de Boer et al. [65] used Fluidigm 48.48 Dynamic
Array™ to evaluate the potential of gene expression as a biomarker of chemical contamination,
using a species of arthropod often employed for ecotoxicological testing. They concluded that
the combination of these analytical platforms and multivariate analysis could be a valuable
tool in ecotoxicology, combining high throughput capacity with analytical sensitivity. In a
similar approach, Harty et al. [66] employed a Fluidigm 96.96 Dynamic Array™ to evaluate
expression profiles of adhesion G protein coupled receptor in zebrafish and their possibilities
as models in human medicine. In another animal model, Tosches et al. [97] employed a
Fluidigm 48.48 Dynamic Array™ to evaluate the pathway of melatonin using a zooplankton.
These platforms also found their applicability in animal production as demonstrated by Robic
et al. [67], who evaluated the influence of an SNP in the transcripts of quantitative trait loci
(QTL), responsible for the accumulation of androsterone in boar fat. In aquaculture, Bonacic
et al. [68] employed OpenArray® plates to evaluate gene expression in lipid metabolism with
diets rich on omega-3 and omega-6 in fish. Other applications include immunological studies
and virology. The work from Rosa et al. [69] reported the usefulness of Fluidigm 96.96 Dynamic
Array™ to evaluate different transcriptional patterns in the cattle tick Rhipicephalus microplus
in response to microbial challenge. Their findings demonstrated that certain pathogens cause
downregulation of immune-related genes, favoring their survival and vector colonization. In
parallel, Tierney et al. [70] used a Fluidigm 48.48 Dynamic Array™ to analyze the transcript
patterns of Epstein-Barr virus with the aim of know more about the first phases of infection.
3.2.3. High-throughput real-time PCR in microRNA-based transcriptomics
The discovery of microRNAs (miRNAs) has changed the previous concepts of gene expression
regulation. These small noncoding RNA molecules with a length between 21 and 25 nucleo-
tides and they are found in plants, animals, and some viruses [71]. In human, miRNA are found
in plasma, urine, cerebrospinal fluid, and saliva and have an important function as post-
transcriptional regulators of gene expression. Their different levels have been associated with
a wide range of human diseases [72] and have potential as biomarkers [73]. There are many
technologies for the measurement of miRNAs such as microarrays, NGS, and real-time PCR,
being the last one and the most sensitive and reproducible method. Also, the releasing of high-
throughput real-time PCR platforms have allowed a reduction of costs and minimization of
the time required for detection of broad miRNA signatures.
Some studies have demonstrated the applicability of nanoliter-scale PCR in the analysis of
microRNA. Jang et al. [74] made an interplatform comparative study using conventional real-
time PCR, microarrays and Fluidigm 48.48/96.96 Dynamic Array™, concluding that these
High-Throughput Platforms in Real-Time PCR and Applications
http://dx.doi.org/10.5772/65760
27
nanoscale platforms could be used to develop cost-effective and customized assays, with rapid
turnaround for profiling and validating of miRNA expression. Farr et al. [13] performed a
similar study comparing the usefulness of high-throughput platforms for validation of a
circulation microRNA signature in diabetic retinopathy. An interesting point of this work is
the direct comparison of the two principal high-throughput real-time PCR platforms com-
mercially available: OpenArray® and Dynamic Array™. Authors found that OpenArray®
system was the most reproducible platform with less inter- and intrarun variations and had a
more user-friendly software for further analyses. One of the main problems of Dynamic
Array™ is the replicate variability, caused by their low-volume assay. OpenArray® use the
double of the volume used in Dynamic Array™, and in this sense researchers found that
variability increased in parallel with volume reductions.
This technology was rapidly introduced in human medicine because of their potential uses in
this field. Keller et al. [75] evaluated the expression profiles of 863 microRNAs in 454 blood
samples using SmartChip real-time PCR system and found a disease association with micro-
RNAs profiles. Their potential as biomarkers was shown by Mooney et al. [76], who found
minimal variations in miRNA profiles of healthy volunteers according to sex and sample
timing using OpenArray® plates. Given their value as biological markers, the field of oncology
research soon adopted this methodology to screen the microRNA profiles of this disease. Thus,
Hudson et al. [77] used the commercially available TaqMan® OpenArray® Human MicroRNA
Panel and found overexpression of miR-10a and miR-375 in medullary thyroid carcinoma.
Using the same panel, others researchers achieve great results for lung cancer detection [78],
for rectal cancer [79], and brain metastasis in mutant lung cancers [80]. With Fluidigm 96.96
Dynamic Array™, Kara et al. [81] discovered the downregulation of 18 miRNAs in patients
with colorectal cancer. Research on other human diseases has also used miRNA molecules as
biomarkers. The microRNA profiles have been related to human late-onset Fuchs' dystrophy
[82], Alzheimer [83] or Crohn disease [84]. It is remarkable that most of these studies used the
TaqMan® OpenArray® Human microRNA Panel.
The results of the studies cited before show the great importance of miRNA in human diseases
and how their variation could be a good biomarker for diagnostic purposes. Most of these
studies used the TaqMan® OpenArray® Human microRNA Panel for the screening of
microRNA, showing its potential. However, this panel only allows the analysis of three
samples simultaneously, eliminating one of the mains advantages of high-throughput real-
time PCR platforms. So, the next step would be the validation of panels with fewer microRNA
targets focused on specific diseases, giving the possibility of introducing more samples at the
same time. Apart from diagnostic of diseases, microRNA also has potential in other fields.
Benson et al. [85] observed that rifampin treatment modifies the microRNA profiles. Thus, it
is possible that the administration of determinate substances causes a variation of miRNA
profile in humans allowing their use as a new-generation anti-doping biomarkers [86]. This
knowledge can be transferred to food safety and by employing miRNA as biomarkers in the
administration of banned substances in animal production, thus developing, for instance, a
panel of miRNA for each drug [71].
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3.3. Detection of pathogens and antimicrobial and virulence genes
One of the great applications of high-throughput real-time PCR platforms is the detection of
pathogen for medical and food safety purposes. The development of real-time PCR was a major
breakthrough in microbiological analyses. The classical microbiology used large incubation
times with the need of multistep procedures for the detection of some bacteria. Real-time PCR
avoids the waiting time caused for this incubation. Likewise, real-time PCR allows quantifi-
cation of genes with great importance, such as resistance or virulence genes.
The introduction of the technology described in this chapter allows performing a large number
of assays in a large number of samples. These achievements have a great importance in hospital
and food safety microbiology labs. In 2008, Stedtfeld et al. [18] developed an OpenArray® plate
to detect human pathogens based on the detection and quantification of virulence factors of
these pathogens. Another step forward in microbiological analysis was the OpenArray® panel
developed by Gonzalez et al. [87], which allow the identification, including virulotype, and
subtypes of O157 and non-O157 enterohemorrhagic Escherichia coli with a panel of 28 genes in
a single anaylisis. All of this will make the characterization of Enterohemorrhagic Escherichia
coli possible in less than 4 h, avoiding the use of large number of conventional PCR assays,
saving time and money. In a similar study, Dhoubhadel et al. [88] used the Fluidigm 48.48
Dynamic Array™ for molecular serotyping and serotype-specific quantification of Streptococ-
cus pneumoniae. Researchers found a good correlation between conventional serotyping and
serotype by nanofluidic PCR system. The use of this high-throughput technology brings great
saving of time but it also has the drawback of needing a large number of samples for the
analysis. In this context, it is important to mention that sometimes microbiology labs do not
have a large number of samples for a specific assay.
In the work of Ishi et al. [89], Dynamic Array™ platform and TaqMan® Probes were used for
the simultaneous quantification of food and waterborne pathogens as Salmonella Typhimuri-
um, Listeria monocitogenes, Vibrio parahaemolyticus, Clostridium perfringens or even viruses. One
of the advantages of use Dynamic Array™ for pathogen detection is the possibility of changing
which microorganism to detect according to the current needs. The existing results show the
possibility of routine monitoring of multiple pathogens in large number of food and water
samples. Grigorenko et al. [90] developed an OpenArray® panel to detect bloodborne
pathogens as viruses, bacteria, or parasites in humans. The aim was to detect these pathogens
in blood donors. With this technology they were able to detect at least 10 cell/ml blood of
Trypanosoma cruzi and 10,000 cell/ml blood of Escherichia coli, a detection limit that seems too
high for Escherichia coli.
On certain occasions, instead of detecting pathogenic microorganism, it is interesting to detect
virulence and resistance genes. With regard to this, Looft et al. [91] used OpenArray® to
evaluate the change in resistance genes in swine intestinal microbiome in pigs fed with feed
supplemented with antibiotics. Tseng et al. [92] evaluated the virulence gene content of Shiga
Toxin-Producing Escherichia coli from finishing swine using Fluidigm 96.96 Dynamic Array™.
The antibiotic resistoma in sewage sludge composting was evaluated by Su et al. [93] using
the Smart-Chip real-time PCR system and a chip containing almost 300 antibiotic resistance
genes. Similarly, Xu et al. [94] screened 285 antibiotic resistance genes in drinking water
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treatment plants and distribution systems. These studies give an idea of the potential of these
platforms for wide screening, as it is possible to evaluate most of the important antibiotic
resistance genes in one run. All of this permits to establish a relationship between this resistoma
and other factors such as microbial community or water treatments.
4. Conclusions
The development of high-throughput real-time PCR platforms was a big step in real-time PCR.
There was an important development from the 384 reactions that could be performed at the
same time in conventional systems to the 12,288 reactions that can be performed in one run in
nanoliter-scale platforms. However, this nanoliter real-time PCR has yet some drawbacks in
comparison to other techniques. While in NGS it is possible to analyze unknown sequences,
with real-time it is necessary to know beforehand the target sequence to design the primers
and the probes. While in microarray technology it is possible to analyze thousands of sequences
at the same time, the highest target with these nanoliter platforms is 1200 different sequences.
However high-throughput real-time PCR platforms have great advantages, achieving opera-
tional improvements that the other platforms are not capable of reaching. They have a great
facility for processing large number of samples, the sample consumption is less than in other
platforms and the time necessary to get the results is at most 7 h with easy protocols. Also, the
analysis of the results is relatively easy and the price is relatively cheap. But without any doubt
the great advantage of these platforms is their specificity and their sensibility, which makes
them the gold standard in quantification analysis. Although, fast mode is common in real-time
PCR, high-throughput platforms do not work in this mode. Therefore, the introduction of fast
mode would be another big step because it would increase the number of assays that can be
performed in one day. Another clear challenge is to increase the number of assays and samples
that can be analyzed at the same time. Even though one platform can perform 1200 assays in
one run, this is only for one sample. Being capable of performing this number of assays for a
large number of samples would place real-time PCR at the same level than others platforms
for genotyping and transcriptomics analyses. The future of these platforms goes through the
design of plates for routine applications in medicine, nutrition, or food safety. However, in
food safety and microbiology this technique has been under used until now. Thus, the
development of plates that could analyze the microbiome of multiple types of samples could
be a great advance approaching this technique to NGS for microbiome analysis.
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